Blog Post

Blog Post

Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD

By Sujatha Gurunathan | September 30, 2021
Blog Post

Improving Air Travel for People Living with a Disability

By MDA Staff | September 27, 2021
Blog Post

Clinical Trial Alert: Phase 2 Study of Ataluren in Children with Nonsense Mutation DMD

By MDA Staff | September 20, 2021
Blog Post

Clinical Trial Alert: Phase 3 Study of High Dose Eteplirsen in Boys with DMD

By MDA Staff | September 20, 2021
Blog Post

Aging and Neuromuscular Disease Share Symptoms – and Solutions

By Shaila Wunderlich | September 10, 2021
Blog Post

Recognizing and Treating CMT in Kids

By Elizabeth Millard | September 10, 2021
Blog Post

Clinical Trial Alert: Phase 2 Study of Ifetroban in Individuals with DMD

By MDA Staff | August 18, 2021
Blog Post

Clinical Trial Alert: Phase 2/3 and Open-Label Extension Study of ASP0367 in Individuals with Primary Mitochondrial Myopathy

By MDA Staff | August 9, 2021
Blog Post

FDA Approves Sanofi Genzyme’s Nexviazyme for Treatment of Pompe Disease

By MDA Staff | August 6, 2021
Blog Post

It Is OK to Have Mixed Feelings About Resuming Activities After Being Vaccinated

By Claire Sykes | August 5, 2021